Parsippany, New Jersey. Edenbridge Pharmaceuticals, LLC today announced that it has partnered with Validus Pharmaceuticals LLC to launch an exclusive authorized generic version of Bumex®* (bumetanide tablets). Edenbridge’s Bumetanide Tablets in 0.5mg, 1mg and 2mg dosage strengths will begin shipping shortly. Bumetanide is a loop diuretic indicated for the treatment of edema associated with congestive heart failure, hepatic and renal disease, including the nephrotic syndrome. For more information please contact the Company directly at: info@dexcelpharmausa.com.
Bumetanide Tablets, USP Launch
Specialty Products
To learn more about our specialty products, vigabatrin and Yargesa®, and how you may be able to save, please visit the Products page or navigate to a product-specific page.
Specialty Products
To learn more about our specialty products, vigabatrin and Yargesa®, and how you may be able to save, please visit the Products page or navigate to a product-specific page.